{"FP": [{"generated": ["cannabis"], "gold": [], "text": "The case described herein demonstrates the importance of considering the pharmacokinetic and pharmacodynamic effects of cannabis and an individual\u2019s pharmacogenomic (PGx) data when evaluating a patient\u2019s medication regimen for therapeutic response and/or adverse drug events."}, {"generated": ["cannabis"], "gold": [], "text": "Additionally, a previous study evaluated patients with PD and their subsequent reactions to cannabis use, reporting that one out of five patients experienced hallucinations [12]."}, {"generated": ["morphine"], "gold": [], "text": "Given this patient\u2019s genetic results, guidelines, and current pain status, the clinical pharmacist suggested morphine as an alternative, as it does not utilize CYP2D6 for metabolism [34]."}, {"generated": ["HDIs"], "gold": [], "text": "To date an increasing number of studies in evaluating HDIs have been reported [11]."}, {"generated": ["cytochrome P450 (CYP450)"], "gold": [], "text": "The cytochrome P450 (CYP450) family of enzymes especially plays an important role in the biotransformation of about 70% of xenobiotics and other endogenous substances [14]."}, {"generated": ["extracts from Newbouldia laevis and Cassia abbreviata"], "gold": ["extracts"], "text": "This study concentrated on investigating the effects of potential interaction between extracts from Newbouldia laevis and Cassia abbreviata on CYP1A2, CYP2C9, and CYP2C19 activities."}, {"generated": ["original starting material", "powdered material"], "gold": ["extracts", "soluble extract"], "text": "Since the intestinal absorption and plasma concentration of each test compound are not known and with the knowledge that herbal extracts have different bioavailability [24], the bioavailable concentration was estimated using the % yield (weight extracted powdered material/weight of original starting material) to give the soluble extract available in the GIT tract."}, {"generated": ["original starting material", "powdered material"], "gold": ["extracts", "soluble extract"], "text": "Since the intestinal absorption and plasma concentration of each test compound are not known and with the knowledge that herbal extracts have different bioavailability [24], the bioavailable concentration was estimated using the % yield (weight extracted powdered material/weight of original starting material) to give the soluble extract available in the GIT tract."}, {"generated": ["water"], "gold": [], "text": "Extraction was performed using water to mimic the indigenous mode of extraction."}, {"generated": ["SLC22 family members"], "gold": [], "text": "Currently, there are 29 putative SLC22 family members, 18 of which are believed to be OATs."}, {"generated": ["Oat3", "Oat1"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["Oat3", "Oat1"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["alternative medicines"], "gold": [], "text": "Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001)."}, {"generated": ["polymerase chain reaction"], "gold": [], "text": "Detection of the CYP2C9*2 and CYP2C9*3 alleles were carried out using a polymerase chain reaction based restriction fragment length polymorphism (polymerase chain reaction-RFLP) analysis."}, {"generated": ["grapefruit", "caffeine-containing beverages"], "gold": [], "text": "All participants were asked not to drink caffeine-containing beverages and to refrain from grapefruit from the day before until 2 days after taking gliclazide."}, {"generated": ["grapefruit", "caffeine-containing beverages"], "gold": [], "text": "All participants were asked not to drink caffeine-containing beverages and to refrain from grapefruit from the day before until 2 days after taking gliclazide."}, {"generated": ["black cohosh"], "gold": [], "text": "The American College of Obstetrics and Gynecology included black cohosh as a possible remedy for the vasomotor symptoms of menopause [15]."}, {"generated": ["herbal supplement"], "gold": [], "text": "This case culminated in liver failure despite discontinuation of the herbal supplement [4]."}, {"generated": ["Naranjo"], "gold": [], "text": "Naranjo [8] Causality Scale for Adverse Drug Reactions."}, {"generated": ["levofloxacin"], "gold": [], "text": "Levofloxacin (LVFX) is used to treat numerous bacterial infections belonging to the third-generation fluoroquinolone antibiotic family [8]."}, {"generated": ["drug"], "gold": [], "text": "In vivo distribution studies are crucial in drug research as they can be performed to demonstrate the pharmacokinetic features of a drug [21, 22]."}, {"generated": ["Polygonum capitatum"], "gold": [], "text": "Polygonum capitatum may inhibit the entrance of LVFX into blood, thereby directly affecting its distribution rate in the tissue."}, {"generated": ["constituents of KF", "extract"], "gold": [], "text": "Furthermore, the extract and constituents of KF have been shown to possess anticancer, antioxidant, anti-osteoporosis, and anti-inflammatory properties (Nadia et al., 2012; Fathilah et al., 2013)."}, {"generated": ["constituents of KF", "extract"], "gold": [], "text": "Furthermore, the extract and constituents of KF have been shown to possess anticancer, antioxidant, anti-osteoporosis, and anti-inflammatory properties (Nadia et al., 2012; Fathilah et al., 2013)."}, {"generated": ["96-well microplates", "200 \u03bcL"], "gold": ["FBS"], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["96-well microplates", "200 \u03bcL"], "gold": ["FBS"], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["rooibos extracts"], "gold": ["extracts"], "text": "The anti-diabetic [9,10], anti-obesity [11], and cardio-protective effects [12,13,14] of rooibos extracts are of specific relevance given the global increase in the prevalence of diabetes and obesity [15,16,17]."}, {"generated": ["flavonoids"], "gold": [], "text": "Flavonoids, common in the diet, are responsible for the modulation of the clinically relevant CYP2C8, CYP2C9, and CYP3A4 enzymes [31]."}, {"generated": ["compounds", "extracts"], "gold": [], "text": "Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4."}, {"generated": ["compounds", "extracts"], "gold": [], "text": "Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4."}, {"generated": ["DMSO", "acetonitrile", "methanol"], "gold": [], "text": "The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a\u2013c)."}, {"generated": ["DMSO", "acetonitrile", "methanol"], "gold": [], "text": "The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a\u2013c)."}, {"generated": ["DMSO", "acetonitrile", "methanol"], "gold": [], "text": "The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a\u2013c)."}, {"generated": ["distilled water"], "gold": [], "text": "Stock solutions (10 mg/mL) were prepared by diluting the extracts and compounds in distilled water."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": [], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": [], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": [], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["rooibos extracts"], "gold": ["extracts"], "text": "Statistical analyses were performed using GraphPad Prism This in vitro study indicated that combining nutraceuticals containing rooibos extracts with drugs metabolized by CYP2C8 and CYP3A4 could potentially alter the pharmacodynamics and safety of these drugs."}, {"generated": ["commercially available E. purpurea extract"], "gold": [], "text": "The commercially available E. purpurea extract did not significantly alter the pharmacokinetics of docetaxel."}, {"generated": ["docetaxel"], "gold": [], "text": "The following pharmacokinetic parameters of docetaxel were calculated: area under the plasma concentration\u2013time curve from time zero to infinity (AUC0\u2013\u221e), elimination half-life (t1/2) and maximum plasma concentration (Cmax)."}, {"generated": ["docetaxel"], "gold": [], "text": "Statistical analysis  For each patient, the values of AUC0\u2013\u221e, t1/2 and Cmax of docetaxel in cycle 1 (before E. purpurea) were compared with values obtained in cycle 2 (after E. purpurea)."}, {"generated": ["E. purpurea"], "gold": [], "text": "Compared with the clinical studies in which significant induction of CYP3A4 by E. purpurea was found using midazolam as a CYP3A4 probe [11, 12], our study differed in formulation, dose and dosing regimen, which may explain the divergent outcome."}, {"generated": ["extracts", "DTAI"], "gold": [], "text": "In contrast, contents of DTAI or other alkylamides in the extracts used in the midazolam studies [11, 12] were not specified."}, {"generated": ["extracts", "DTAI"], "gold": [], "text": "In contrast, contents of DTAI or other alkylamides in the extracts used in the midazolam studies [11, 12] were not specified."}, {"generated": ["roots", "alkylamides", "leaves"], "gold": [], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": ["roots", "alkylamides", "leaves"], "gold": [], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": ["roots", "alkylamides", "leaves"], "gold": [], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": ["CYP3A4"], "gold": [], "text": "Thus, the risk of CYP3A4-mediated interactions may be product dependent."}, {"generated": ["green tea"], "gold": [], "text": "Previous in vitro studies have reported the inhibitory effect of green tea on p-glycoprotein (p-gp) encoded by ABCB1."}, {"generated": ["whole blood samples"], "gold": [], "text": "DNA was isolated from the 200 \u00b5L of whole blood samples using a QIAamp DNA Blood Mini Kit (Qiagen, Germantown, MD, USA)."}, {"generated": ["EGCG", "EGC", "EC", "ECG"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["EGCG", "EGC", "EC", "ECG"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["EGCG", "EGC", "EC", "ECG"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["EGCG", "EGC", "EC", "ECG"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["GTC", "digoxin"], "gold": [], "text": "To identify the effect of ABCB1 genotype on the pharmacokinetic alteration of digoxin by GTC, we compared the percentage changes from Day 1 (digoxin alone treatment) of AUC This study investigated the effect of GTC on the pharmacokinetics of digoxin."}, {"generated": ["GTC", "digoxin"], "gold": [], "text": "To identify the effect of ABCB1 genotype on the pharmacokinetic alteration of digoxin by GTC, we compared the percentage changes from Day 1 (digoxin alone treatment) of AUC This study investigated the effect of GTC on the pharmacokinetics of digoxin."}, {"generated": ["methotrexate"], "gold": [], "text": "Biliary excretion, but not urinary excretion, of methotrexate decreased in the RGE repeated administration group, compared to that in the control group."}, {"generated": ["RGE"], "gold": [], "text": "After RGE was orally administered to rats at single or multiple doses for 1 or 2 weeks, the plasma concentrations of ginsenosides were also monitored."}, {"generated": ["RGE"], "gold": [], "text": "Next, we investigated the effects of RGE on the biliary excretion of Mrp2 substrate drug in rats."}, {"generated": ["RGE"], "gold": [], "text": "However, other ginsenosides, such as Rg3, Re, and Rh1, were not detected in rat plasma despite their high content in RGE (Table 1 and Table 2)."}, {"generated": ["red ginseng products"], "gold": [], "text": "In particular, the beneficial effects of red ginseng products for reducing the symptoms of rheumatoid arthritis have been proven in animals and humans [24,25,26,27,36]."}, {"generated": ["total RNA"], "gold": [], "text": "The concentration of total RNA was determined by Nano Vue Plus (GE healthcare Korea, Seoul, Korea)."}, {"generated": ["liver samples"], "gold": [], "text": "Briefly, total protein was obtained by homogenizing 100 mg of liver samples with equal volume of a tissue lysis buffer."}, {"generated": ["RGE"], "gold": [], "text": "Pharmacokinetic studies started 2 h after the last RGE treatment."}, {"generated": ["Red ginseng extract"], "gold": [], "text": "Sample Availability: Red ginseng extract are available from the authors."}, {"generated": ["centrifuging"], "gold": [], "text": "After centrifuging at 3500\u2009rpm for 10\u2009min, the supernatant was obtained and frozen at \u221240\u2009\u00b0C until analysis."}, {"generated": ["AC", "rat liver microsomes"], "gold": [], "text": "The maximum plasma concentration (C Rat liver microsomes were used to determine the metabolic rate of AC."}, {"generated": ["AC", "rat liver microsomes"], "gold": [], "text": "The maximum plasma concentration (C Rat liver microsomes were used to determine the metabolic rate of AC."}, {"generated": ["acetonitrile"], "gold": [], "text": "The highest recovery was obtained using acetonitrile as a protein precipitant."}, {"generated": ["digoxin"], "gold": [], "text": "Experiments in mice have shown that the AUC of digoxin is increased by gavage and intravenous injection."}, {"generated": ["cytochrome P450 (P450)"], "gold": [], "text": "The most important class of enzymes involved in human drug metabolism is cytochrome P450 (P450), which occurs as a superfamily of related monooxygenase forms responsible for oxidative metabolism of xenobiotics and endogenous compounds (Nebert et al., 2013)."}, {"generated": ["CAW-R61J", "C. asiatica", "Plant Material"], "gold": [], "text": "C. asiatica Plant Material and Preparation of CAW-R61J."}, {"generated": ["CAW-R61J", "C. asiatica", "Plant Material"], "gold": [], "text": "C. asiatica Plant Material and Preparation of CAW-R61J."}, {"generated": ["CAW-R61J", "C. asiatica", "Plant Material"], "gold": [], "text": "C. asiatica Plant Material and Preparation of CAW-R61J."}, {"generated": ["DMSO"], "gold": [], "text": "DMSO was added to the CAW-R61J dosing solutions to 0.1% (v/v) such that all treatment conditions contained 0.1% DMSO."}, {"generated": ["Prism 8.0.2"], "gold": [], "text": "All curve fitting was carried out using Prism 8.0.2 (GraphPad Software, San Diego, CA)."}, {"generated": ["CA derivatives"], "gold": [], "text": "It will also be important to examine possible interactions of CA derivatives with phase II drug-metabolizing enzymes."}, {"generated": ["Agilent 6470 Triple Quadrupole LC-MS/MS system"], "gold": [], "text": "Fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide levels in each sample were determined using an Agilent 6470 Triple Quadrupole LC-MS/MS system (Agilent, Wilmington, DE, USA)."}, {"generated": ["quality control samples"], "gold": [], "text": "Three concentrations of quality control (QC) samples were prepared at low, medium, and high concentrations in the range of the standard calibration curves."}, {"generated": ["acetonitrile"], "gold": [], "text": "Then, 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS) was added to the reconstituted standard curves."}, {"generated": ["autosampler"], "gold": [], "text": "Post-preparative stability was evaluated by comparing the extracted QC samples maintained in the autosampler at 6 \u00b0C for 24 h (compared with the untreated QC samples)."}, {"generated": ["authentic standards"], "gold": [], "text": "The ionization mode and mass transition from Q1 to Q3 were selected based on the product ion scan results of authentic standards and previously published reports (Figure 1)."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["medicinal plants"], "gold": [], "text": "There is substantial evidence supporting the potential of medicinal plants in combating diseases, especially in developing countries [12,13,14,15]."}, {"generated": ["CYP2B6"], "gold": [], "text": "Genetic polymorphism in CYP2B6 have been implicated in variations in the activity of the enzyme in metabolizing xenobiotics [26]."}, {"generated": ["herbal extracts"], "gold": ["extracts", "soluble extract"], "text": "Since the intestinal absorption and plasma concentrations of each test compound are not known, and with the knowledge that herbal extracts have different bioavailability [28], the estimated bioavailable concentration was calculated using the % yield to give the soluble extract available in the GI tract."}, {"generated": ["phytochemical profiling"], "gold": [], "text": "The advantage of phytochemical profiling is that similar drug interacting constituents could be identified in other related herbs that are used for therapeutic purposes and that necessary mechanistic studies are performed on them."}, {"generated": ["Launaea taraxacifolia", "Boerhavia diffusa", "Hyptis suaveolens", "Myrothamnus flabellifolius"], "gold": ["extracts"], "text": "The study showed that Launaea taraxacifolia Hyptis suaveolens, Boerhavia diffusa and Myrothamnus flabellifolius extracts caused a concentration-dependent inhibition in CYP2B6."}, {"generated": ["Launaea taraxacifolia", "Boerhavia diffusa", "Hyptis suaveolens", "Myrothamnus flabellifolius"], "gold": ["extracts"], "text": "The study showed that Launaea taraxacifolia Hyptis suaveolens, Boerhavia diffusa and Myrothamnus flabellifolius extracts caused a concentration-dependent inhibition in CYP2B6."}, {"generated": ["Launaea taraxacifolia", "Boerhavia diffusa", "Hyptis suaveolens", "Myrothamnus flabellifolius"], "gold": ["extracts"], "text": "The study showed that Launaea taraxacifolia Hyptis suaveolens, Boerhavia diffusa and Myrothamnus flabellifolius extracts caused a concentration-dependent inhibition in CYP2B6."}, {"generated": ["Launaea taraxacifolia", "Boerhavia diffusa", "Hyptis suaveolens", "Myrothamnus flabellifolius"], "gold": ["extracts"], "text": "The study showed that Launaea taraxacifolia Hyptis suaveolens, Boerhavia diffusa and Myrothamnus flabellifolius extracts caused a concentration-dependent inhibition in CYP2B6."}, {"generated": ["72 hours", "room temperature", "purified water", "24 hours", "supernatant"], "gold": [], "text": "The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated."}, {"generated": ["72 hours", "room temperature", "purified water", "24 hours", "supernatant"], "gold": [], "text": "The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated."}, {"generated": ["72 hours", "room temperature", "purified water", "24 hours", "supernatant"], "gold": [], "text": "The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated."}, {"generated": ["72 hours", "room temperature", "purified water", "24 hours", "supernatant"], "gold": [], "text": "The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated."}, {"generated": ["72 hours", "room temperature", "purified water", "24 hours", "supernatant"], "gold": [], "text": "The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated."}, {"generated": ["garlic oil", "St. John\u2019s wort", "Panax ginseng", "Ginkgo biloba"], "gold": [], "text": "Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of St. John\u2019s wort, garlic oil, Panax ginseng, and Ginkgo biloba affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4 activity in elderly subjects."}, {"generated": ["garlic oil", "St. John\u2019s wort", "Panax ginseng", "Ginkgo biloba"], "gold": [], "text": "Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of St. John\u2019s wort, garlic oil, Panax ginseng, and Ginkgo biloba affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4 activity in elderly subjects."}, {"generated": ["garlic oil", "St. John\u2019s wort", "Panax ginseng", "Ginkgo biloba"], "gold": [], "text": "Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of St. John\u2019s wort, garlic oil, Panax ginseng, and Ginkgo biloba affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4 activity in elderly subjects."}, {"generated": ["garlic oil", "St. John\u2019s wort", "Panax ginseng", "Ginkgo biloba"], "gold": [], "text": "Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of St. John\u2019s wort, garlic oil, Panax ginseng, and Ginkgo biloba affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4 activity in elderly subjects."}, {"generated": ["ultraviolet absorption spectra"], "gold": [], "text": "Peaks were assigned by a comparison of retention times and ultraviolet absorption spectra."}, {"generated": ["midazolam"], "gold": [], "text": "[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John\u2019s wort when more conventional \u201carea-under-the-curve\u201d methods were utilized to determine midazolam clearance."}, {"generated": ["St. John\u2019s wort"], "gold": [], "text": "[54] Thus, a potential interaction may exist between these agents and St. John\u2019s wort."}, {"generated": ["allyl sulfide"], "gold": [], "text": "[42] The difference in extent of inhibition between the two age groups hints at either an age-related diminution in CYP2E1 responsivity or a dissimilarity in allyl sulfide content between the garlic supplements."}, {"generated": ["Panax ginseng"], "gold": [], "text": "Like G. biloba, Panax ginseng appears to have little effect on the activities of the specific CYP isoforms investigated in this study."}, {"generated": ["ginseng"], "gold": [], "text": "[62] CYP2C9 is the principal isoform involved in the biotransformation of warfarin (more particularly the active enantiomer, S-warfarin) and the aforementioned reports hint strongly at a ginseng-mediated induction of this enzyme."}, {"generated": ["quinine", "(3-hydroxyquinine)", "plasma"], "gold": [], "text": "Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method."}, {"generated": ["quinine", "(3-hydroxyquinine)", "plasma"], "gold": [], "text": "Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method."}, {"generated": ["quinine", "(3-hydroxyquinine)", "plasma"], "gold": [], "text": "Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method."}, {"generated": ["venous blood"], "gold": [], "text": "Sample collection  Venous blood samples (5ml) was collected into heparinised tubes at time zero (just before the administration of quinine sulphate tablets)) and at 1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h after each participant received quinine alone or concurrently with the scheduled dose of G. kola."}, {"generated": ["quinine", "3-hydroxyquinine"], "gold": [], "text": "The limit of quantitation was 0.37\u00b5g/ml and 0.5\u00b5g/ml for quinine and for 3-hydroxyquinine respectively."}, {"generated": ["quinine", "3-hydroxyquinine"], "gold": [], "text": "The limit of quantitation was 0.37\u00b5g/ml and 0.5\u00b5g/ml for quinine and for 3-hydroxyquinine respectively."}, {"generated": ["quinine"], "gold": [], "text": "The AUC0\u2013\u221e of quinine was slightly reduced by about 9 %."}, {"generated": ["quinine", "G. kola"], "gold": [], "text": "Moreover, parameters such as T1/2 and CL/F of quinine that relates to elimination in both study groups were also not altered significantly in the presence of G. kola."}, {"generated": ["quinine", "G. kola"], "gold": [], "text": "Moreover, parameters such as T1/2 and CL/F of quinine that relates to elimination in both study groups were also not altered significantly in the presence of G. kola."}, {"generated": ["normal saline"], "gold": [], "text": "Briefly, whole blood (0.5\u2009mL) was diluted twofold with freshly prepared normal saline and incubated at 37\u2009\u00b0C for at least 6\u2009min."}, {"generated": ["International normalized ratio"], "gold": [], "text": "International normalized ratio  International normalized ratio was measured at each blood sampling time before and after warfarin dosing using a BFT II analyser."}, {"generated": ["standard human plasma"], "gold": [], "text": "Percentage factor activity for each sample was obtained from a standard curve constructed using different dilutions of standard human plasma of known factor activity and clotting time."}, {"generated": ["warfarin"], "gold": [], "text": "Pharmacokinetic\u2013pharmacodynamic modelling  The population PKPD parameter estimates for warfarin are presented in the Table 3."}, {"generated": ["cranberry juice"], "gold": ["juice"], "text": "(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin."}, {"generated": ["cranberry juice"], "gold": ["juice"], "text": "(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10\u2009mg), which made this end point difficult to assess."}, {"generated": ["valerian"], "gold": [], "text": "Academic Editor: Igho J. Onakpoya In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs."}, {"generated": ["valerian"], "gold": [], "text": "However, they state that warnings that valerian (Valeriana officinalis) may stimulate CYP 3A4."}, {"generated": ["valerian root extracts"], "gold": [], "text": "Recommended daily doses of valerian root extracts are about 600\u2009mg, usually taken as capsules or tablets."}, {"generated": ["TOXLIT", "MEDLINE"], "gold": [], "text": "A search with the search terms (valerian or valeriana) was conducted in the databases MEDLINE and TOXLIT, via DIMDI (Cologne, Germany)."}, {"generated": ["TOXLIT", "MEDLINE"], "gold": [], "text": "A search with the search terms (valerian or valeriana) was conducted in the databases MEDLINE and TOXLIT, via DIMDI (Cologne, Germany)."}, {"generated": ["extraction solvent ethanol 70%", "valerian extract"], "gold": [], "text": "Daily before going to bed, participants took two tablets, with 500\u2009mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51\u2009mg/tablet), for 14 subsequent days."}, {"generated": ["extraction solvent ethanol 70%", "valerian extract"], "gold": [], "text": "Daily before going to bed, participants took two tablets, with 500\u2009mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51\u2009mg/tablet), for 14 subsequent days."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["valerian"], "gold": [], "text": "That therapeutic safety regarding interactions is high in valerian and is mentioned in the respective monograph of the HMPC [18] and also in a fact sheet of the Office of Dietary Supplements at the NIH [32]."}, {"generated": ["in vitro data"], "gold": [], "text": "In a data base for interactions of medicinal drugs (MedIQ), the rating \u201cweak interaction\u201d is given for CYP-isoenzymes, P-gp, and UGT, based on in vitro data."}, {"generated": ["clarithromycin", "rifampin"], "gold": [], "text": "Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively."}, {"generated": ["clarithromycin", "rifampin"], "gold": [], "text": "Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively."}, {"generated": ["herb extract complex (RHC)", "red ginseng"], "gold": [], "text": "This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms."}, {"generated": ["herb extract complex (RHC)", "red ginseng"], "gold": [], "text": "This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms."}, {"generated": ["compounds"], "gold": [], "text": "Therefore, evaluation of inhibition of compounds towards UGT isoforms was always carried out using recombinant UGTs and nonspecific substrates [19,20,21]."}, {"generated": ["celastrol"], "gold": [], "text": "The second plot (Figure 3C) using slope (obtained from Lineweaver-Burk plot) vs. celastrol concentration showed that the inhibition kinetic parameter (Ki) was 0.49 \u03bcM."}, {"generated": ["it"], "gold": [], "text": "Additionally, it can metabolize many drugs including clofibric acid and valproic acid [25]."}, {"generated": ["Du et al."], "gold": [], "text": "The previous study performed by Du et al."}, {"generated": ["celastrol"], "gold": [], "text": "Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["ginseng"], "gold": [], "text": "The therapeutic benefits of ginseng include anti-diabetic and anti-inflammatory effect and anti-oxidative response on chronic liver disease [3,4,5,6,7,8]."}, {"generated": ["ginsenosides", "valsartan", "RGE"], "gold": [], "text": "The results suggest that valsartan could be used as a model drug for investigating OATP (in human) or Oatp (in rats)-mediated herb\u2013drug interaction between valsartan and RGE or ginsenosides."}, {"generated": ["ginsenosides", "valsartan", "RGE"], "gold": [], "text": "The results suggest that valsartan could be used as a model drug for investigating OATP (in human) or Oatp (in rats)-mediated herb\u2013drug interaction between valsartan and RGE or ginsenosides."}, {"generated": ["ginsenosides", "valsartan", "RGE"], "gold": [], "text": "The results suggest that valsartan could be used as a model drug for investigating OATP (in human) or Oatp (in rats)-mediated herb\u2013drug interaction between valsartan and RGE or ginsenosides."}, {"generated": ["RGE", "Rc"], "gold": [], "text": "The results revealed that the repeated administration of RGE and high dose of Rc did not significantly induce herb\u2013drug interactions involving valsartan (Figure 5 and Figure 8)."}, {"generated": ["RGE", "Rc"], "gold": [], "text": "The results revealed that the repeated administration of RGE and high dose of Rc did not significantly induce herb\u2013drug interactions involving valsartan (Figure 5 and Figure 8)."}, {"generated": ["plasma samples"], "gold": [], "text": "After centrifugation of the blood samples at 16,000\u00d7 g for 10 min, aliquots (50 \u03bcL each) of plasma samples were stored at \u221280 \u00b0C until the analysis of ginsenosides and valsartan."}, {"generated": ["blood samples"], "gold": [], "text": "Blood samples were collected via the retro-orbital vein at 0.17, 0.33, 0.67, 1.5, 2, 4, 8, 24, and 48 h after valsartan dosing."}, {"generated": ["valsartan"], "gold": [], "text": "AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["1,1\u2032,3,3\u2032-tetramethoxypropane"], "gold": [], "text": "A 1,1\u2032,3,3\u2032-tetramethoxypropane was used to construct the calibration curve as the standard [32] (reference value: 0.54\u20131.32 pg/mL)."}, {"generated": ["polyphenols"], "gold": [], "text": "In fact, polyphenols determine the antioxidant activity, and this positive relationship renders a trend in many medicinal plants [36]."}, {"generated": ["herb"], "gold": [], "text": "particularly illustrated an increase in the SOD, CAT, and GPx levels, while the MDA level more significantly decreased compared to other groups using only one herb [17]."}, {"generated": ["ginger"], "gold": [], "text": "demonstrated that ginger could decrease the FBS level by the mechanism of serotonin receptors which activate pancreatic \u03b2 cells to release insulin [56]."}, {"generated": ["phenolic phytochemicals of spearmint"], "gold": [], "text": "showed that phenolic phytochemicals of spearmint possessed hypoglycemic, and antioxidant attributes [57]."}, {"generated": ["darunavir-ritonavir", "E. purpurea"], "gold": [], "text": "Figure \u200bFigure11 displays the ritonavir concentration-versus-time profile, and Table \u200bTable22 lists the pharmacokinetic parameters of ritonavir after multiple-dose administration of darunavir-ritonavir alone or in combination with E. purpurea."}, {"generated": ["darunavir-ritonavir", "E. purpurea"], "gold": [], "text": "Figure \u200bFigure11 displays the ritonavir concentration-versus-time profile, and Table \u200bTable22 lists the pharmacokinetic parameters of ritonavir after multiple-dose administration of darunavir-ritonavir alone or in combination with E. purpurea."}, {"generated": ["echinacea"], "gold": [], "text": "The variability in the effect of echinacea on darunavir pharmacokinetics we observed in this cohort may imply some degree of uncertainty in the CYP3A4 inductive/inhibitory potential of this herbal remedy."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "EGb 761\u00ae has no relevant effect on the in vivo activity of the major CYP enzymes in humans and therefore has no relevant potential to cause respective metabolic drug\u2013drug interactions."}, {"generated": ["Ginkgo biloba extract"], "gold": [], "text": "Ginkgo biloba extract is a popular herbal remedy used for a variety of disorders."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "The following treatments were administered for 8\u00a0days each: placebo twice daily (treatment A), EGb 761\u00ae 120\u00a0mg twice daily (treatment B), and EGb 761\u00ae 240\u00a0mg in the morning and placebo in the evening (treatment C)."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "A maximum exposure was realized with a 240-mg EGb 761\u00ae daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761\u00ae components was reached, and 1\u00a0week is typically sufficient to achieve full induction [35]."}, {"generated": ["warfarin", "herbal medicines"], "gold": [], "text": "The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin."}, {"generated": ["warfarin", "herbal medicines"], "gold": [], "text": "The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin."}, {"generated": ["herb", "product", "extract"], "gold": [], "text": "An herb was defined as a product or an extract originating from a single botanical source."}, {"generated": ["herb", "product", "extract"], "gold": [], "text": "An herb was defined as a product or an extract originating from a single botanical source."}, {"generated": ["herb", "product", "extract"], "gold": [], "text": "An herb was defined as a product or an extract originating from a single botanical source."}, {"generated": ["herbal preparations"], "gold": [], "text": "Extraction and formulation method, composition, and bioanalytical data regarding the herbal preparations from the included RCTs are summarized Table 2."}, {"generated": ["trials"], "gold": [], "text": "For incomplete outcome data, seven trials [21\u201324, 26, 28, 29] reported detailed information regarding attrition by describing the number and reasons for withdrawal."}, {"generated": ["studies"], "gold": [], "text": "Some studies pointed out such limitations, that is, that case reports often result in misleading conclusions for multiple reasons [39, 40]."}, {"generated": ["echinacea"], "gold": [], "text": "However, an in vivo study indicated that echinacea did not significantly affect the metabolism of drugs metabolized by CYP2C9 [47]."}, {"generated": ["warfarin"], "gold": [], "text": "She had no history of warfarin use, but warfarin was detected in her blood serum analysis."}, {"generated": ["activated partial thromboplastin time", "prothrombin time", "international normalized ratio"], "gold": [], "text": "At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven."}, {"generated": ["activated partial thromboplastin time", "prothrombin time", "international normalized ratio"], "gold": [], "text": "At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven."}, {"generated": ["activated partial thromboplastin time", "prothrombin time", "international normalized ratio"], "gold": [], "text": "At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven."}, {"generated": ["warfarin", "super-warfarin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["warfarin", "super-warfarin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["herbal products"], "gold": [], "text": "This limitation applies particularly to the prediction of herb\u2013drug interactions, as herbal products are typically mixtures of multiple constituents that can alter ADME processes via multiple mechanisms."}, {"generated": ["curcumin"], "gold": [], "text": "Curcumin commercially available as pure powder capsule (95%) was obtained from Quality Supplements and Vitamins (Fort Lauderdale, FL, USA)."}, {"generated": ["Traditional Chinese medicine"], "gold": [], "text": "Traditional Chinese medicine accounted for most of the interactions (n = 17), followed by food (n = 10), dietary supplements (n = 3), and other herbs/botanicals (n = 3)."}, {"generated": ["CBZ"], "gold": [], "text": "Despite its clinical popularity, CBZ possesses several pharmacokinetic properties which make it prone to interaction with coadministered substances, including drugs, herbal products, and food [7]."}, {"generated": ["honey"], "gold": [], "text": "Although honey was shown to decrease the oral bioavailability of CBZ in rabbits, it had no effect on the pharmacokinetic parameters of CBZ in human [63\u201365]."}, {"generated": ["folinic acid", "nicotinamide"], "gold": [], "text": "As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70]."}, {"generated": ["folinic acid", "nicotinamide"], "gold": [], "text": "As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70]."}, {"generated": ["eleven databases"], "gold": [], "text": "In order to achieve a comprehensive literature search, a total of eleven databases were searched."}, {"generated": ["HepaRG cell line"], "gold": [], "text": "HepaRG cell line, derived from a hepatocellular carcinoma, could express a large panel of liver-specific enzymes [5,6,7]."}, {"generated": ["aspirin"], "gold": [], "text": "After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12]."}, {"generated": ["Figure 1"], "gold": [], "text": "A total of 22 compounds were identified or tentatively identified (Figure 1)."}, {"generated": ["PON"], "gold": [], "text": "The influence test for PON was conducted by the method of Furlong et al."}, {"generated": ["Trizol", "Total RNA"], "gold": [], "text": "Briefly, 2 \u00d7 10 Total RNA was extracted from the cells using the Trizol (CW0581, CWbio, Beijing, China)."}, {"generated": ["Trizol", "Total RNA"], "gold": [], "text": "Briefly, 2 \u00d7 10 Total RNA was extracted from the cells using the Trizol (CW0581, CWbio, Beijing, China)."}, {"generated": ["commercial kits"], "gold": [], "text": "Inhibition of cytochrome P450 enzymes (CYPs) was quantified by commercial kits and inhibition of drug transporters by use of fluorescent probe substrates."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "Neither Samento nor Banderol increased intracellular calcein fluorescence in L-MDR1 cells over-expressing human P-glycoprotein (P-gp), indicating lack of P-gp inhibition (data not shown)."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "Neither Samento nor Banderol increased intracellular calcein fluorescence in L-MDR1 cells over-expressing human P-glycoprotein (P-gp), indicating lack of P-gp inhibition (data not shown)."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "The highest inhibition was demonstrated for CYP3A4 by Samento (around 40% at a concentration of 1%) and Banderol (around 20% at a concentration of 1%) and for CYP2C19 by Banderol (about 20% at a concentration of 1%)."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "The highest inhibition was demonstrated for CYP3A4 by Samento (around 40% at a concentration of 1%) and Banderol (around 20% at a concentration of 1%) and for CYP2C19 by Banderol (about 20% at a concentration of 1%)."}, {"generated": ["Samento"], "gold": [], "text": "To demonstrate possible influences on aryl hydrocarbon receptor (AhR), another important transcription factor regulating e.g., CYP1A, we also tested whether Samento can activate AhR and found only a minor effect compared to the positive control omeprazole (Figure 4B)."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "This study, therefore, scrutinized in vitro whether Samento and Banderol can inhibit the activity or induce the expression of important drug metabolizing enzymes and drug transporters."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "This study, therefore, scrutinized in vitro whether Samento and Banderol can inhibit the activity or induce the expression of important drug metabolizing enzymes and drug transporters."}, {"generated": ["rifampicin", "St. John\u2019s Wort"], "gold": [], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["rifampicin", "St. John\u2019s Wort"], "gold": [], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["pheophorbide A"], "gold": [], "text": "BCRP inhibition was tested by flow cytometry using pheophorbide A as a specific BCRP substrate in MDCKII-BCRP cells compared to the parental cell line MDCKII as described previously [24]."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "Therefore, Samento and Banderol were tested up to a dilution of 1% in the induction assay."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "Therefore, Samento and Banderol were tested up to a dilution of 1% in the induction assay."}, {"generated": ["RNA", "cDNA", "GeneElute Mammalian Total RNA Miniprep Kit", "RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit"], "gold": [], "text": "RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit according to the manufacturers\u2019 instructions."}, {"generated": ["RNA", "cDNA", "GeneElute Mammalian Total RNA Miniprep Kit", "RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit"], "gold": [], "text": "RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit according to the manufacturers\u2019 instructions."}, {"generated": ["RNA", "cDNA", "GeneElute Mammalian Total RNA Miniprep Kit", "RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit"], "gold": [], "text": "RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit according to the manufacturers\u2019 instructions."}, {"generated": ["RNA", "cDNA", "GeneElute Mammalian Total RNA Miniprep Kit", "RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit"], "gold": [], "text": "RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit according to the manufacturers\u2019 instructions."}, {"generated": ["Samento"], "gold": [], "text": "(a) Concentration-dependent effect of Samento and the positive control rifampicin (insert) on pregnane x receptor (PXR) activity."}, {"generated": ["Samento"], "gold": [], "text": "Effect of Samento on CYP2J2 mRNA decay in LS180 cells."}, {"generated": ["woohwangcheongsimwon suspension"], "gold": [], "text": "Drug interactions may occur between woohwangcheongsimwon suspension and bupropion."}, {"generated": ["tablet form"], "gold": [], "text": "Its original formulation was in a tablet form."}, {"generated": ["PCR"], "gold": [], "text": "CYP2B6 genotyping  CYP2B6 genotyping was performed by pyrosequencing of polymerase chain reaction (PCR) products as described previously [13]."}, {"generated": ["TurboIonSpray interface"], "gold": [], "text": "The TurboIonSpray interface was operated in positive ion mode at 5500 V and 500\u00b0C."}, {"generated": ["Analyst software"], "gold": [], "text": "The analytical data were processed using Analyst software (version 1.4, Applied Biosystems, Foster City, CA)."}, {"generated": ["woohwangcheongsimwon suspension"], "gold": [], "text": "Go to: Discussion  In this study, we examined the CYP2B6 inhibitory effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion."}, {"generated": ["tyrosine kinases"], "gold": [], "text": "The overexpression or somatic mutations of tyrosine kinases are dysregulated in various malignancies [3]."}, {"generated": ["APG"], "gold": [], "text": "The APG-pretreated rats showed significant inhibition of the Pgp/MDR1 protein, that is 65.38% and 69.90% inhibition, respectively, as compared to DAS alone (p < 0.05)."}, {"generated": ["APG"], "gold": [], "text": "The inhibitory potential of APG on BCRP/ABCG2 protein expression was investigated and shown in Figure 5A,B."}, {"generated": ["APG"], "gold": [], "text": "The APG-pretreated rats showed significant inhibition of the BCPR/ABCG2 protein that is (66.77% and 41.06% inhibition, respectively) as compared to DAS only (p < 0.05)."}, {"generated": ["herbs"], "gold": [], "text": "Inhibition and/or induction of drug-metabolizing enzymes (DME) and or drug transporters mediated by herbs is the most typical mechanism of herb-drug interactions, which in turn alters the pharmacokinetic disposition of the drug [24,25]."}, {"generated": ["electrospray ionization"], "gold": [], "text": "Electrospray ionization was used to ionize samples in a positive direction."}, {"generated": ["DAS", "APG"], "gold": [], "text": "Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment."}, {"generated": ["DAS", "APG"], "gold": [], "text": "Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment."}, {"generated": ["phytochemicals"], "gold": [], "text": "Phytochemical-mediated modulation of cytochrome P-450 (CYP) activity may underlie many herb-drug interactions."}, {"generated": ["SC extract"], "gold": [], "text": "The purpose of this study was to evaluate the effect of SC extract supplementation on quadriceps muscle strength (QMS) and lactate at rest in adult women."}, {"generated": ["database searching", "literature selection"], "gold": [], "text": "Figure\u00a01 summarizes the process of database searching and literature selection."}, {"generated": ["database searching", "literature selection"], "gold": [], "text": "Figure\u00a01 summarizes the process of database searching and literature selection."}, {"generated": ["etoposide", "doxorubicin", "5-FU", "cyclophosphamide", "cisplatin", "carboplatin", "UFT"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["etoposide", "doxorubicin", "5-FU", "cyclophosphamide", "cisplatin", "carboplatin", "UFT"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["etoposide", "doxorubicin", "5-FU", "cyclophosphamide", "cisplatin", "carboplatin", "UFT"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["etoposide", "doxorubicin", "5-FU", "cyclophosphamide", "cisplatin", "carboplatin", "UFT"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["etoposide", "doxorubicin", "5-FU", "cyclophosphamide", "cisplatin", "carboplatin", "UFT"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["etoposide", "doxorubicin", "5-FU", "cyclophosphamide", "cisplatin", "carboplatin", "UFT"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["etoposide", "doxorubicin", "5-FU", "cyclophosphamide", "cisplatin", "carboplatin", "UFT"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["GATA-3", "T-box protein expressed in T cells (T-bet)", "programmed death 1 (PD-1)", "Bax", "Forkhead box protein 3 (Foxp3)"], "gold": [], "text": "Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171]."}, {"generated": ["GATA-3", "T-box protein expressed in T cells (T-bet)", "programmed death 1 (PD-1)", "Bax", "Forkhead box protein 3 (Foxp3)"], "gold": [], "text": "Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171]."}, {"generated": ["GATA-3", "T-box protein expressed in T cells (T-bet)", "programmed death 1 (PD-1)", "Bax", "Forkhead box protein 3 (Foxp3)"], "gold": [], "text": "Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171]."}, {"generated": ["GATA-3", "T-box protein expressed in T cells (T-bet)", "programmed death 1 (PD-1)", "Bax", "Forkhead box protein 3 (Foxp3)"], "gold": [], "text": "Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171]."}, {"generated": ["GATA-3", "T-box protein expressed in T cells (T-bet)", "programmed death 1 (PD-1)", "Bax", "Forkhead box protein 3 (Foxp3)"], "gold": [], "text": "Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171]."}, {"generated": ["estrogen receptor", "breast tumors"], "gold": [], "text": "Approximately 70\u201380% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer."}, {"generated": ["estrogen receptor", "breast tumors"], "gold": [], "text": "Approximately 70\u201380% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer."}, {"generated": ["Viscum album extracts"], "gold": [], "text": "Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10\u201313]."}, {"generated": ["Dextromethorphan"], "gold": [], "text": "Dextromethorphan in vitro inhibition profiles of CYP2D6 by reference inhibitor: Quinidine (0.1-1-2-5-10-100 \u03bcM)."}, {"generated": ["captopril"], "gold": [], "text": "daily for two weeks at morning and a single captopril dose (4.5\u2009mg/200\u2009g BW; p.o.)"}, {"generated": ["blood collection process"], "gold": [], "text": "The animals were anaesthetized before blood collection process."}, {"generated": ["captopril"], "gold": [], "text": "The within-run accuracy and precision of captopril analysis ranged from 1.56% to 14.38% (Table 3)."}, {"generated": ["2-4-dibromoacetophenone"], "gold": [], "text": "In this experiment, we used 2-4-dibromoacetophenone as a derivatization agent to prevent the sulfhydryl group in captopril from binding to plasma sulfhydryl groups."}, {"generated": ["ammonia"], "gold": [], "text": "Ammonia was used during derivatization since the reaction is optimal at basic pH."}, {"generated": ["formic acid"], "gold": [], "text": "The reaction was then stopped by adding formic acid [17]."}, {"generated": ["H. sabdariffa extract"], "gold": [], "text": "Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter."}, {"generated": ["Agilent 1290 series liquid chromatography system"], "gold": [], "text": "The analysis was performed on an Agilent 1290 series liquid chromatography system (Agilent Technologies, Palo Alto, CA, USA)."}, {"generated": ["GLT", "AC"], "gold": [], "text": "The results suggest that the herb-drug interaction between GLT and AC might occur when they were co-administered."}, {"generated": ["GLT", "AC"], "gold": [], "text": "The results suggest that the herb-drug interaction between GLT and AC might occur when they were co-administered."}, {"generated": ["Eugenia jambolana"], "gold": [], "text": "Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus."}, {"generated": ["aqueous extract", "double maceration technique", "dried seed of Eugenia jambolana"], "gold": ["aqueous extract", "double maceration technique"], "text": "Dried seed of Eugenia jambolana were powdered and used for preparation of aqueous extract by using the double maceration technique."}, {"generated": ["extract"], "gold": [], "text": "After seven days, the extract was filtered and the filtrate was stored in refrigerator until next processing."}, {"generated": ["filtrate"], "gold": [], "text": "It was filtered and the filtrate obtained in this step was mixed with the previous filtrate."}, {"generated": ["SITA", "PRM"], "gold": [], "text": "Mass chromatograms of SITA and PRM (Peak for SITA at 0.642min, PRM at 0.482\u202fmin)."}, {"generated": ["SITA", "PRM"], "gold": [], "text": "Mass chromatograms of SITA and PRM (Peak for SITA at 0.642min, PRM at 0.482\u202fmin)."}, {"generated": ["indomethacin", "A. officinarum"], "gold": [], "text": "Our results first clarified that oral administration of A.\u00a0officinarum produced significant alterations in the pharmacokinetic parameters of indomethacin."}, {"generated": ["indomethacin", "A. officinarum"], "gold": [], "text": "Our results first clarified that oral administration of A.\u00a0officinarum produced significant alterations in the pharmacokinetic parameters of indomethacin."}, {"generated": ["tissue homogenates"], "gold": [], "text": "Tissue homogenates were treated by the same method as plasma sample preparation except dilution process."}, {"generated": ["bile"], "gold": [], "text": "The bile was collected during 0\u20131\u00a0h, 1\u20132\u00a0h, 2\u20133\u00a0h, 3\u20134\u00a0h, 4\u20135\u00a0h, 5\u20136\u00a0h and 6\u20137\u00a0h after dosing."}, {"generated": ["Dong quai", "Ginkgo biloba", "Danshen"], "gold": [], "text": "or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.)."}, {"generated": ["Dong quai", "Ginkgo biloba", "Danshen"], "gold": [], "text": "or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.)."}, {"generated": ["Dong quai", "Ginkgo biloba", "Danshen"], "gold": [], "text": "or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.)."}, {"generated": ["Gouqizi"], "gold": [], "text": "In China, Gouqizi is a popular component of the daily diet, making the prohibition of its consumption in patients taking warfarin difficult to implement."}, {"generated": ["Gouqizi"], "gold": [], "text": "However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin."}, {"generated": ["Lycium barbarum L."], "gold": [], "text": "The interaction study of warfarin and Lycium barbarum L.  Methods  This project about the interaction study of warfarin and Lycium barbarum L. is approved by Fujian Medical University Union Hospital ethics committee (NO: 2015KY002)."}, {"generated": ["HS extract"], "gold": [], "text": "Animal studies have consistently shown that consumption of HS extract reduces blood pressure in a dose dependent manner."}, {"generated": ["HS varieties"], "gold": [], "text": "The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45]."}, {"generated": ["cholesterol RCT interventions"], "gold": [], "text": "Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides."}, {"generated": ["HS"], "gold": [], "text": "One brief 15 day study reported a significant increase in total cholesterol among hypertensive patients administered HS [18]."}, {"generated": ["HS"], "gold": [], "text": "Studies demonstrate that HS consumption does not adversely effect liver and kidney function at lower doses, but may be hepatotoxic at extremely high doses."}, {"generated": ["bosutinib"], "gold": [], "text": "Conversely, S. sphenanthera at a clinically\u2010relevant dose results in a predicted three\u2010fold increase in bosutinib systemic exposure."}, {"generated": ["FRE", "GRT"], "gold": [], "text": "Go to: 2."}, {"generated": ["FRE", "GRT"], "gold": [], "text": "Go to: 2."}, {"generated": ["NADPH"], "gold": [], "text": "The reaction was initiated by the addition of NADPH and terminated by placing the tubes on a cooling block (Selleckchem, Houston, TX, USA)."}, {"generated": ["three lignans"], "gold": [], "text": "Prediction differences of pharmacokinetic parameters for the three lignans, expressed as the ratio of PBPK model prediction to clinically\u2010reported parameter values were also evaluated."}, {"generated": ["Schisandra lignans"], "gold": [], "text": "PBPK simulations were also carried out to evaluate the capability of PBPK models of Schisandra lignans in predicting the extent of interactions with midazolam and tacrolimus with trial designs as detailed in Table 3."}, {"generated": ["Ginkgo biloba"], "gold": [], "text": "Ginkgo biloba is available as an over-the-counter drug and reported to cause haemorrhage when coadministered with other antiplatelet agents."}, {"generated": ["warfarin", "Gegen", "Danshen"], "gold": [], "text": "Sixty Sprague\u2013Dawley rats were used to investigate the effects of warfarin (0.2\u00a0mg/kg), Danshen (240 or 480\u00a0mg/kg) and Gegen (240 or 480\u00a0mg/kg) both in isolation and combination."}, {"generated": ["warfarin", "Gegen", "Danshen"], "gold": [], "text": "Sixty Sprague\u2013Dawley rats were used to investigate the effects of warfarin (0.2\u00a0mg/kg), Danshen (240 or 480\u00a0mg/kg) and Gegen (240 or 480\u00a0mg/kg) both in isolation and combination."}, {"generated": ["warfarin", "Gegen", "Danshen"], "gold": [], "text": "Sixty Sprague\u2013Dawley rats were used to investigate the effects of warfarin (0.2\u00a0mg/kg), Danshen (240 or 480\u00a0mg/kg) and Gegen (240 or 480\u00a0mg/kg) both in isolation and combination."}, {"generated": ["microsomes"], "gold": [], "text": "Microsomes incubation, Real Time-Polymerase Chain Reaction and Western blot was applied respectively to study the activity, mRNA expression and protein expression of CYP, VKOR and TM."}, {"generated": ["Gegen", "Danshen"], "gold": [], "text": "We also monitored the effects of Danshen/Gegen on the activities and mRNA and protein expression levels of VKOR and TM (for pharmacodynamic analysis)."}, {"generated": ["Gegen", "Danshen"], "gold": [], "text": "We also monitored the effects of Danshen/Gegen on the activities and mRNA and protein expression levels of VKOR and TM (for pharmacodynamic analysis)."}, {"generated": ["raw herbs"], "gold": [], "text": "The raw herbs were morphologically authenticated by an in-house herbalist and chemically by the thin layer chromatography in accordance with the Chinese Pharmacopoeia 2005 [36]."}, {"generated": ["Racemic warfarin", "diclofenac sodium", "naringin"], "gold": [], "text": "The plant names in current study were used according to the latest revision in \u201cThe Plant List\u201d ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA)."}, {"generated": ["Racemic warfarin", "diclofenac sodium", "naringin"], "gold": [], "text": "The plant names in current study were used according to the latest revision in \u201cThe Plant List\u201d ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA)."}, {"generated": ["Racemic warfarin", "diclofenac sodium", "naringin"], "gold": [], "text": "The plant names in current study were used according to the latest revision in \u201cThe Plant List\u201d ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA)."}, {"generated": ["solvent A"], "gold": [], "text": "The linear gradient elution was carried out as follows with a total running time of 90\u00a0min: solvent A was kept at 5\u00a0% for the first 5\u00a0min, and then increased to 10, 17, 35 and 90\u00a0% in the next 13, 12, 10 and 30\u00a0min, respectively, then returned to 5\u00a0% in 5\u00a0min and equilibrated for 15\u00a0min before the next injection."}, {"generated": ["Danshen"], "gold": [], "text": "Furthermore, no inductive effects were observed in the mRNA expression level of CYP2C6 for both doses of Danshen compared with the vehicle control group."}, {"generated": ["warfarin"], "gold": [], "text": "Danshen and Gegen elicit their effects by improving microcirculation and inhibiting platelet aggregation [24, 32], whereas warfarin exerts its anticoagulant effect by inhibiting the activity of VKOR and inducing TM."}, {"generated": ["warfarin", "DFG"], "gold": [], "text": "The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32]."}, {"generated": ["warfarin", "DFG"], "gold": [], "text": "The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32]."}, {"generated": ["Gegen", "Danshen"], "gold": [], "text": "Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20\u201322]."}, {"generated": ["Gegen", "Danshen"], "gold": [], "text": "Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20\u201322]."}, {"generated": ["warfarin"], "gold": [], "text": "Algorithms that integrate the relevant genetic and physical factors into comprehensive, individualized predictive models were used to predict warfarin dose [54]."}, {"generated": ["aqueous extract of Danshen", "major tanshinone components"], "gold": ["aqueous extract"], "text": "This finding is also supported by Yueng\u2019s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58]."}, {"generated": ["aqueous extract of Danshen", "major tanshinone components"], "gold": ["aqueous extract"], "text": "This finding is also supported by Yueng\u2019s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58]."}, {"generated": ["publication by Beer et al."], "gold": [], "text": "Sample preparation was based on the publication by (Beer et al."}, {"generated": ["human plasma"], "gold": [], "text": "The extraction recovery from human plasma was considered acceptable with a mean recovery of greater than 88% for each analyte."}, {"generated": ["filtered", "concentrated", "freeze-dried"], "gold": [], "text": "Each mixture was filtered, concentrated, and freeze\u2010dried."}, {"generated": ["filtered", "concentrated", "freeze-dried"], "gold": [], "text": "Each mixture was filtered, concentrated, and freeze\u2010dried."}, {"generated": ["filtered", "concentrated", "freeze-dried"], "gold": [], "text": "Each mixture was filtered, concentrated, and freeze\u2010dried."}, {"generated": ["acetic acid", "HPLC-grade acetonitrile"], "gold": [], "text": "Acetic acid and HPLC\u2010grade acetonitrile were purchased from Merck (LiChrosolv GG, Darmstadt, Germany)."}, {"generated": ["acetic acid", "HPLC-grade acetonitrile"], "gold": [], "text": "Acetic acid and HPLC\u2010grade acetonitrile were purchased from Merck (LiChrosolv GG, Darmstadt, Germany)."}, {"generated": ["positive ion mode", "multiple reaction monitoring (MRM)"], "gold": [], "text": "Multiple reaction monitoring (MRM) mode using positive ion mode."}, {"generated": ["positive ion mode", "multiple reaction monitoring (MRM)"], "gold": [], "text": "Multiple reaction monitoring (MRM) mode using positive ion mode."}, {"generated": ["herbs"], "gold": [], "text": "In vitro herb\u2013drug interactions studies are mostly conducted for commonly used herbs to evaluate and predict potentially significant in vivo herb\u2013drug interactions and to help design appropriate in vivo herb\u2013drug interaction studies (Fasinu, Bouic, & Rosenkranz, 2012; Awortwe, Bouic, Masimirembwa, & Rosenkranz, 2013)."}, {"generated": ["extract"], "gold": [], "text": "Though we did not report any inhibition of CYP isoenzymes by Allium sativum, the discrepancies in these reports and ours may be due to the extraction procedure, assay method, concentration and type of the extract used and enzyme sources."}, {"generated": ["aqueous extract", "oven-dried Allium sativum bulbs"], "gold": ["aqueous extract of oven\u2010dried"], "text": "In this study, aqueous extract of oven\u2010dried Allium sativum bulbs was used."}, {"generated": ["aqueous extract", "oven-dried Allium sativum bulbs"], "gold": ["aqueous extract of oven\u2010dried"], "text": "In this study, aqueous extract of oven\u2010dried Allium sativum bulbs was used."}, {"generated": ["aqueous extract", "Moringa oleifera leaves"], "gold": ["Aqueous extract"], "text": "Aqueous extract of Moringa oleifera leaves showed weak inhibition of CYP1A2 and CYP2C9."}, {"generated": ["Alstonia boonei", "herb", "Gongronema latifolium"], "gold": [], "text": "Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb\u2013drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb."}, {"generated": ["Alstonia boonei", "herb", "Gongronema latifolium"], "gold": [], "text": "Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb\u2013drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb."}, {"generated": ["Alstonia boonei", "herb", "Gongronema latifolium"], "gold": [], "text": "Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb\u2013drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb."}, {"generated": ["simvastatin", "simvastatin hydroxy acid", "lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["simvastatin", "simvastatin hydroxy acid", "lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["simvastatin", "simvastatin hydroxy acid", "lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["echinacea", "policosanol"], "gold": [], "text": "Therefore, two commonly used herbal medicines, echinacea and policosanol were investigated for their potential to interact with warfarin."}, {"generated": ["echinacea", "policosanol"], "gold": [], "text": "Therefore, two commonly used herbal medicines, echinacea and policosanol were investigated for their potential to interact with warfarin."}, {"generated": ["PCR-RFLP"], "gold": [], "text": "CYP2C9 and VKORC1 genotyping  The CYP2C9*1,*2 and *3 polymorphisms of CYP2C9 were detected by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) analysis."}, {"generated": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["phytochemicals"], "gold": [], "text": "Key phytochemicals were individually assessed for their impact on CYP1A2 activity."}, {"generated": ["filtered", "liquor", "type 1 Whatman filter paper"], "gold": ["liquor"], "text": "The resulting liquor was suction-filtered through type 1 Whatman filter paper and stored in a sealed darkened glass container."}, {"generated": ["filtered", "liquor", "type 1 Whatman filter paper"], "gold": ["liquor"], "text": "The resulting liquor was suction-filtered through type 1 Whatman filter paper and stored in a sealed darkened glass container."}, {"generated": ["Waters Alliance 2690 HPLC", "Waters LCT Time of Flight Mass Spectrometer"], "gold": [], "text": "High resolution LC-MS was conducted using a Waters LCT Time of Flight Mass Spectrometer (Waters Micromass Ltd., Wilmslow, UK), with a Waters Alliance 2690 HPLC and Mass Lynx V4.1 software using similar HPLC conditions to those described above."}, {"generated": ["Waters Alliance 2690 HPLC", "Waters LCT Time of Flight Mass Spectrometer"], "gold": [], "text": "High resolution LC-MS was conducted using a Waters LCT Time of Flight Mass Spectrometer (Waters Micromass Ltd., Wilmslow, UK), with a Waters Alliance 2690 HPLC and Mass Lynx V4.1 software using similar HPLC conditions to those described above."}, {"generated": ["curcumin"], "gold": [], "text": "The pharmacokinetic data revealed that curcumin-treated animals had significantly (p \u2264 0.05) higher area under the plasma concentration-time curve and area under the first moment of plasma drug concentration-time curve."}, {"generated": ["Albuterol"], "gold": [], "text": "Albuterol (as internal standard) was purchased from Sigma-Aldrich Chem."}, {"generated": ["glycyl-sarcosine (Gly-Sar)", "Hygromycin B", "thiazolyl blue tetrazolium bromide (MTT)"], "gold": [], "text": "Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem."}, {"generated": ["glycyl-sarcosine (Gly-Sar)", "Hygromycin B", "thiazolyl blue tetrazolium bromide (MTT)"], "gold": [], "text": "Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem."}, {"generated": ["glycyl-sarcosine (Gly-Sar)", "Hygromycin B", "thiazolyl blue tetrazolium bromide (MTT)"], "gold": [], "text": "Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem."}, {"generated": ["PBS", "dichlorvos"], "gold": [], "text": "The reaction was terminated by adding 5\u202f\u03bcL of 8\u202fmg/mL dichlorvos and then mixed with 600\u202f\u03bcL PBS."}, {"generated": ["PBS", "dichlorvos"], "gold": [], "text": "The reaction was terminated by adding 5\u202f\u03bcL of 8\u202fmg/mL dichlorvos and then mixed with 600\u202f\u03bcL PBS."}, {"generated": ["OS", "rat plasma"], "gold": [], "text": "The incubation system for rat plasma contains 1\u202f\u03bcg/mL of OS and 10% rat plasma since the super-fast reaction rate of 100% rat plasma resulted in no discrimination for nearly all the studied herb/herbal components."}, {"generated": ["OS", "rat plasma"], "gold": [], "text": "The incubation system for rat plasma contains 1\u202f\u03bcg/mL of OS and 10% rat plasma since the super-fast reaction rate of 100% rat plasma resulted in no discrimination for nearly all the studied herb/herbal components."}, {"generated": ["OSA"], "gold": [], "text": "The formation rate of OSA could be significantly suppressed by all the herb/herbal components."}, {"generated": ["herbal extracts", "herbal components"], "gold": [], "text": "The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500\u202f\u03bcg/mL) and all the herbal components (100\u202f\u03bcg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components."}, {"generated": ["herbal extracts", "herbal components"], "gold": [], "text": "The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500\u202f\u03bcg/mL) and all the herbal components (100\u202f\u03bcg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components."}, {"generated": ["herbal components"], "gold": [], "text": "The hydrolase activities in rat plasma may be originated from more than one kind of enzymes (not only hCE1) and the inhibition activities of these herbal components to each kind of hydrolysis enzymes are different."}, {"generated": ["Root of Isatis indigotica"], "gold": [], "text": "Radix Isatidis (Root of Isatis indigotica Fort., Banlangen)."}, {"generated": ["Fruit of Arctium lappa L.", "Niubangzi", "Fructus Arctii"], "gold": [], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["Fruit of Arctium lappa L.", "Niubangzi", "Fructus Arctii"], "gold": [], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["Fruit of Arctium lappa L.", "Niubangzi", "Fructus Arctii"], "gold": [], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["breast cancer patients"], "gold": [], "text": "Of all the cancer patients, breast cancer patients, in particular, are more likely to turn to complementary and alternative medicine (CAM) treatment (Wanchai et al., 2010)."}, {"generated": ["HES", "PIP", "BV"], "gold": [], "text": "A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018)."}, {"generated": ["HES", "PIP", "BV"], "gold": [], "text": "A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018)."}, {"generated": ["HES", "PIP", "BV"], "gold": [], "text": "A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018)."}, {"generated": ["TAM"], "gold": [], "text": "When combined with TAM, it exhibits a significant synergistic inhibitory effect on MCF-7 and T-47D cell growth (Cho et al., 2010)."}, {"generated": ["Mistletoe"], "gold": [], "text": "Mistletoe (Viscum album L.) derived medicinal preparations are widely used and registered as medicines in many European countries."}, {"generated": ["compound", "Jaeumkanghwa soup"], "gold": [], "text": "Jaeumkanghwa soup (JEKHT) is a compound composed of 12 traditional herbs (Jung et al., 2010)."}, {"generated": ["compound", "Jaeumkanghwa soup"], "gold": [], "text": "Jaeumkanghwa soup (JEKHT) is a compound composed of 12 traditional herbs (Jung et al., 2010)."}, {"generated": ["Jiawei Xiaoyao San"], "gold": [], "text": "Jiawei Xiaoyao San (JWXYS) is a very common Chinese herbal formula used by the Chinese for thousands of years (Chen et al., 2014)."}, {"generated": ["GA", "PCA"], "gold": [], "text": "In the transporter-mediated in vitro HDI, GA and PCA presented inhibitory effects on OAT1/3 and inductive effects on MDR1 and BCRP."}, {"generated": ["GA", "PCA"], "gold": [], "text": "In the transporter-mediated in vitro HDI, GA and PCA presented inhibitory effects on OAT1/3 and inductive effects on MDR1 and BCRP."}, {"generated": ["GA", "PCA"], "gold": [], "text": "Consequently, GA and PCA were chosen as PCE tracer components in the pharmacokinetic- and tissue distribution-based HDIs studies."}, {"generated": ["GA", "PCA"], "gold": [], "text": "Consequently, GA and PCA were chosen as PCE tracer components in the pharmacokinetic- and tissue distribution-based HDIs studies."}, {"generated": ["CIP"], "gold": [], "text": "Approximately 60% of CIP is excreted in unchanged form into the urine (Vance-Bryan et al., 1990)."}, {"generated": ["gradient elution", "A"], "gold": [], "text": "The gradient elution program was as follows: 0\u20138.5\u00a0min, 97% A; 8.7\u201311\u00a0min, 60% A; 11.5\u201313.5\u00a0min, 10% A; 14\u201315\u00a0min, 97% A."}, {"generated": ["gradient elution", "A"], "gold": [], "text": "The gradient elution program was as follows: 0\u20138.5\u00a0min, 97% A; 8.7\u201311\u00a0min, 60% A; 11.5\u201313.5\u00a0min, 10% A; 14\u201315\u00a0min, 97% A."}, {"generated": ["supernate"], "gold": [], "text": "The supernate was utilized for the quantification of GA, PCA, and CIP."}, {"generated": ["CHO"], "gold": [], "text": "However, the total AUC for CHO was lower in YM than PLC (13.3 vs. 15.00, p < 0.001)."}, {"generated": ["active ingredients", "YM capsules"], "gold": [], "text": "However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion."}, {"generated": ["active ingredients", "YM capsules"], "gold": [], "text": "However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion."}, {"generated": ["HEK293 cells"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["isoflurane"], "gold": [], "text": "Rats were cannulated with polyethylene tubing (PE-50, Natsume Co, Tokyo, Japan) in the jugular vein for sampling under anesthesia with isoflurane."}, {"generated": ["Mass Hunter software"], "gold": [], "text": "Mass Hunter software (Agilent Technologies) was used for LC-MS/MS system control and data processing."}, {"generated": ["grapefruit juice"], "gold": [], "text": "Since the accidental discovery of the ability of grapefruit juice to alter the pharmacokinetic profiles of felodipine through the inhibition of cytochrome P450 (CYP) and P-glycoprotein (P-gp), more studies have elucidated various mechanisms of HDI [11]."}, {"generated": ["phytoestrogens", "bioactive components of celery"], "gold": [], "text": "Phytoestrogens and other bioactive components of celery can interact with the DMEs, including those in the CYP450 family."}, {"generated": ["phytoestrogens", "bioactive components of celery"], "gold": [], "text": "Phytoestrogens and other bioactive components of celery can interact with the DMEs, including those in the CYP450 family."}, {"generated": ["rhizomes"], "gold": [], "text": "The pharmacological activities of kava have been attributed to kavalactones, which are concentrated in the rhizomes [96]."}, {"generated": ["kava"], "gold": [], "text": "A study in 18 health volunteers did not show any clinically relevant interaction between kava and bromazepam [104]."}, {"generated": ["SJW"], "gold": [], "text": "investigated the ability of SJW to interact with CYP3A4 in a 2-way, open-label crossover study of 21 healthy subjects using midazolam as the probe substrate."}, {"generated": ["P-gp", "CYP3A4"], "gold": [], "text": "CYP3A4 and P-gp are richly expressed in the human small intestinal enterocytes."}, {"generated": ["P-gp", "CYP3A4"], "gold": [], "text": "CYP3A4 and P-gp are richly expressed in the human small intestinal enterocytes."}, {"generated": ["Parsley", "Petroselinum crispum"], "gold": [], "text": "Parsley, Petroselinum crispum, is a food, spice, and also a medicinal herb."}, {"generated": ["Parsley", "Petroselinum crispum"], "gold": [], "text": "Parsley, Petroselinum crispum, is a food, spice, and also a medicinal herb."}, {"generated": ["parsley"], "gold": [], "text": "Parsley is a food, spice, and also a medicinal herb."}, {"generated": ["parsley juice"], "gold": [], "text": "In this patient, we reported the possible effect of parsley juice on the level of sirolimus."}, {"generated": ["Epimedium sagittatum extract"], "gold": ["extract"], "text": "The AUC data showed statistically significant differences between group 1 and 2 and between groups 2 and 3 possibly suggest the herb-drug interaction between Epimedium sagittatum extract and sildenafil."}, {"generated": ["Epimedium sagittatum extract"], "gold": ["extract"], "text": "Second, the pretreatment period of Epimedium sagittatum extract might have been too short to identify the possible herbal drug effect."}, {"generated": ["combined extraction solution"], "gold": [], "text": "The combined extraction solution was then evaporated to dryness."}, {"generated": ["surveys"], "gold": [], "text": "Most surveys on complementary and alternative therapy or supplement use by those patients did not ask for the species used [4,19,29] or were conducted outside of the geographical area of this review [30,31,32], or both [33,34]."}, {"generated": ["plants"], "gold": [], "text": "Thus, two studies from Canada and the USA were screened to find plants that patients might use."}, {"generated": ["Aloe vera"], "gold": [], "text": "A Spanish study reports Aloe vera [37]."}, {"generated": ["leaf powder"], "gold": ["powder"], "text": "Another patient experienced liver injury after taking 500 mg leaf powder every 2\u20133 days as a laxative [117]."}, {"generated": ["bulbs of Allium sativum"], "gold": [], "text": "The European pharmacopoeia monographs pulverized dried bulbs of Allium sativum containing at least 0.45% allicin [154]."}, {"generated": ["ginkgo", "plant"], "gold": [], "text": "Based on cases of severe bleeding events associated with ginkgo [169,170], the plant has been suspected to increase bleeding risk of patients with anticoagulant or platelet inhibiting co-medication."}, {"generated": ["ginkgo", "plant"], "gold": [], "text": "Based on cases of severe bleeding events associated with ginkgo [169,170], the plant has been suspected to increase bleeding risk of patients with anticoagulant or platelet inhibiting co-medication."}, {"generated": ["green tea"], "gold": [], "text": "applied atorvastatin in rats after 3 weeks of drinking green tea or water."}, {"generated": ["CYP"], "gold": [], "text": "They favor CYP, as the patient could be unusually susceptible due to the individual genotype [207]."}, {"generated": ["curcuminoids"], "gold": [], "text": "Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230]."}, {"generated": ["herb"], "gold": [], "text": "This herb has been in use for diabetic treatment for almost two millennia [72]."}, {"generated": ["Lycium"], "gold": [], "text": "Findings such as these suggest that Lycium may have an additive effect when used in combination with conventional antidiabetics [86]."}, {"generated": ["betaxolol", "codeine"], "gold": [], "text": "The internal standards codeine and betaxolol were of USP reference standard."}, {"generated": ["betaxolol", "codeine"], "gold": [], "text": "The internal standards codeine and betaxolol were of USP reference standard."}, {"generated": ["HPLC grade solvents", "general-purpose reagents"], "gold": [], "text": "General-purpose reagents (GPR) were used for extraction processes, while HPLC grade solvents were used for HPLC determinations."}, {"generated": ["HPLC grade solvents", "general-purpose reagents"], "gold": [], "text": "General-purpose reagents (GPR) were used for extraction processes, while HPLC grade solvents were used for HPLC determinations."}, {"generated": ["Zorbax SB-CN column"], "gold": [], "text": "Urine samples were eluted on a Zorbax SB-CN column (5\u00a0\u03bcm, 250\u00a0\u00d7\u00a04.6\u00a0mm)."}, {"generated": ["Asafetida"], "gold": [], "text": "The in vitro formation of DEX metabolites in the presence of Asafetida was compared with the control by using a one-way analysis of variance (ANOVA), and a Post hoc Scheffe\u2019s multiple comparison test with a significant P value \u2a7d0.05."}, {"generated": ["25 \u03bcg/ml concentration"], "gold": [], "text": "The activation was highest at 25\u00a0\u03bcg/ml concentration."}, {"generated": ["Asafetida"], "gold": [], "text": "In conclusion, the significant Asafetida inhibitory effect on CYP3A4 metabolic activity was an important finding of this study."}], "FN": [{"generated": [], "gold": ["chokeberry juice"], "text": "Moreover, as the patient took a commercial preparation of chokeberry juice which did not provide information on the amounts of its compounds, it cannot be excluded that other interactions might have occurred such as the inhibition of transport mechanisms, the activation of the death receptor and other unknown mechanisms."}, {"generated": ["extracts from Newbouldia laevis and Cassia abbreviata"], "gold": ["extracts"], "text": "This study concentrated on investigating the effects of potential interaction between extracts from Newbouldia laevis and Cassia abbreviata on CYP1A2, CYP2C9, and CYP2C19 activities."}, {"generated": ["original starting material", "powdered material"], "gold": ["extracts", "soluble extract"], "text": "Since the intestinal absorption and plasma concentration of each test compound are not known and with the knowledge that herbal extracts have different bioavailability [24], the bioavailable concentration was estimated using the % yield (weight extracted powdered material/weight of original starting material) to give the soluble extract available in the GIT tract."}, {"generated": ["original starting material", "powdered material"], "gold": ["extracts", "soluble extract"], "text": "Since the intestinal absorption and plasma concentration of each test compound are not known and with the knowledge that herbal extracts have different bioavailability [24], the bioavailable concentration was estimated using the % yield (weight extracted powdered material/weight of original starting material) to give the soluble extract available in the GIT tract."}, {"generated": [], "gold": ["extracts"], "text": "Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm \u00d7 100 mm, 1.7 \u00b5m particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe."}, {"generated": [], "gold": ["Sodium Pyruvate", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA"], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": [], "gold": ["Sodium Pyruvate", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA"], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": [], "gold": ["Sodium Pyruvate", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA"], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": [], "gold": ["Sodium Pyruvate", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA"], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["96-well microplates", "200 \u03bcL"], "gold": ["FBS"], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["rooibos extracts"], "gold": ["extracts"], "text": "The anti-diabetic [9,10], anti-obesity [11], and cardio-protective effects [12,13,14] of rooibos extracts are of specific relevance given the global increase in the prevalence of diabetes and obesity [15,16,17]."}, {"generated": [], "gold": ["FRE", "GRT"], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": [], "gold": ["FRE", "GRT"], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": ["rooibos extracts"], "gold": ["extracts"], "text": "Statistical analyses were performed using GraphPad Prism This in vitro study indicated that combining nutraceuticals containing rooibos extracts with drugs metabolized by CYP2C8 and CYP3A4 could potentially alter the pharmacodynamics and safety of these drugs."}, {"generated": [], "gold": ["ethanolic liquid extracts"], "text": "Of these components, caffeic acid derivatives and the more bioavailable alkylamides are found in ethanolic liquid extracts for medicinal use [8]."}, {"generated": ["herbal extracts"], "gold": ["extracts", "soluble extract"], "text": "Since the intestinal absorption and plasma concentrations of each test compound are not known, and with the knowledge that herbal extracts have different bioavailability [28], the estimated bioavailable concentration was calculated using the % yield to give the soluble extract available in the GI tract."}, {"generated": ["herbal extracts"], "gold": ["extracts", "soluble extract"], "text": "Since the intestinal absorption and plasma concentrations of each test compound are not known, and with the knowledge that herbal extracts have different bioavailability [28], the estimated bioavailable concentration was calculated using the % yield to give the soluble extract available in the GI tract."}, {"generated": [], "gold": ["crude herbal extracts"], "text": "Note: values are expressed as mg\u00b7kg Structures of the phenolic compounds identified and quantified from crude herbal extracts (1) Caffeic acid; (2) Catechin; (3) Chlorogenic acid; (4) Epicatechin; (5) p-Coumaric acid."}, {"generated": ["Launaea taraxacifolia", "Boerhavia diffusa", "Hyptis suaveolens", "Myrothamnus flabellifolius"], "gold": ["extracts"], "text": "The study showed that Launaea taraxacifolia Hyptis suaveolens, Boerhavia diffusa and Myrothamnus flabellifolius extracts caused a concentration-dependent inhibition in CYP2B6."}, {"generated": ["cranberry juice"], "gold": ["juice"], "text": "(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin."}, {"generated": ["cranberry juice"], "gold": ["juice"], "text": "(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10\u2009mg), which made this end point difficult to assess."}, {"generated": [], "gold": ["methanolic extract"], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": [], "gold": ["aqueous extracts"], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": [], "gold": ["aqueous extract", "ethyl acetate extract"], "text": "Furthermore, CYP1A-, CYP2C- and CYP3A-inducing agents were found in the ethyl acetate extract, but not in the aqueous extract of Danshen [57]."}, {"generated": [], "gold": ["aqueous extract", "ethyl acetate extract"], "text": "Furthermore, CYP1A-, CYP2C- and CYP3A-inducing agents were found in the ethyl acetate extract, but not in the aqueous extract of Danshen [57]."}, {"generated": ["aqueous extract of Danshen", "major tanshinone components"], "gold": ["aqueous extract"], "text": "This finding is also supported by Yueng\u2019s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58]."}, {"generated": [], "gold": ["aqueous extract"], "text": "Fifty percent inhibitory concentration (IC   where A\u00a0=\u00a0log of concentration of aqueous extract of herb in the incubations."}, {"generated": [], "gold": ["aqueous extracts"], "text": "Three of the plants studied did not exhibit inhibitory potential on any of the eight major human CYP isoenzymes used even at the highest dose of the extract, that is, aqueous extracts of Musa sapientum unripe fruits, Tetracarpidium conophorum seeds, and Allium sativum bulbs."}, {"generated": ["aqueous extract", "oven-dried Allium sativum bulbs"], "gold": ["aqueous extract of oven\u2010dried"], "text": "In this study, aqueous extract of oven\u2010dried Allium sativum bulbs was used."}, {"generated": [], "gold": ["the aqueous extract"], "text": "Structures of phytochemicals identified in the aqueous extract of H. verticillata (aerial, dried)."}, {"generated": [], "gold": ["ethyl acetate extract"], "text": "In a study involving TAM-resistant cell line MCF-7 tam-R, while 10 Evn-50 is an ethyl acetate extract of Vitex negundo L. When used in combination with TAM to treat TAM-resistant MCF-7/TAM-R cells, it significantly reduces cell viability, inhibits cell growth, induces apoptosis, and reverses TAM resistance of MCF-7/TAM-R cells (Hu et al., 2012)."}, {"generated": ["Epimedium sagittatum extract"], "gold": ["extract"], "text": "The AUC data showed statistically significant differences between group 1 and 2 and between groups 2 and 3 possibly suggest the herb-drug interaction between Epimedium sagittatum extract and sildenafil."}, {"generated": ["Epimedium sagittatum extract"], "gold": ["extract"], "text": "Second, the pretreatment period of Epimedium sagittatum extract might have been too short to identify the possible herbal drug effect."}, {"generated": [], "gold": ["extract"], "text": "Maxim extract are available from the authors."}, {"generated": ["leaf powder"], "gold": ["powder"], "text": "Another patient experienced liver injury after taking 500 mg leaf powder every 2\u20133 days as a laxative [117]."}, {"generated": [], "gold": ["Asafetida resin alcoholic extract"], "text": "In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig."}]}